trending Market Intelligence /marketintelligence/en/news-insights/trending/grvu5m6ur28bxyt_6bkaow2 content esgSubNav
In This List

Wize Pharma implements 1-for-24 reverse stock split

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Wize Pharma implements 1-for-24 reverse stock split

Israel's Wize Pharma Inc. implemented a 1-for-24 reverse split of its common stock, effective March 5.

The biopharmaceutical company said the split will reduce the number of issued and outstanding common stock to about 4.3 million from about 104 million.

Wize Pharma's split-adjusted stock will trade under the ticker symbol WIZPD for 20 days, after which time the D will be removed and the stock will resume trading under the ticker symbol WIZP.